SafeSpace Global Corporation (SSGC) Appoints COO

Northrop Grumman (NOC) secured a $21M U.S. Army contract to develop a mobile, protected version of its Integrated Battle Command System, aiding missile defense modernization. The company will provide two manufacturing units. According to the company, this contract supports the Army's air and missile defense upgrades. NOC is traded on the NYSE.

Skydance, formed from the Paramount-Warner Bros. Discovery merger, raised Discovery+ prices: ad-supported tier to $6.99/month, ad-free to $11.99/month. Existing subscribers get 30-day notice. This is the service's second price hike in 2025. Skydance plans to merge streaming services, but details are unclear. The company aims for $6B in cost savings over three years, with $80B in debt.

AbbVie's SKYRIZI showed higher rates of endoscopic remission and ulcer-free endoscopy in Crohn's disease patients at weeks 12 and 24 compared to placebo, according to the AFFIRM Phase 3 trial. The results support FDA approval for a subcutaneous induction regimen. SKYRIZI is already approved for other autoimmune conditions.

UBS initiated coverage of TechnipFMC (FTI) with a Buy rating and $89 price target, citing growth in subsea production systems. The stock rose 1.1% on Tuesday.

Lockheed Martin (LMT) announced a partnership with Avio to expand U.S. production of solid rocket motors, investing $500M in a new Virginia facility. LMT offers a 2.69% dividend yield, 50% payout ratio, and 5.4% 3-year dividend growth. The stock is undervalued with a GF Value of $567.85 vs. $505.50 price, and has a GF Score of 86/100. Institutional ownership is strong, but insiders sold $4M in shares.

Qualcomm won a jury ruling against Arm, claiming Arm violated their licensing agreement. Arm's stock fell 1% post-verdict. Arm is valued at $255.06, 29.8% above GF Value™ of $196.51, with a GF Score™ of 70/100. Analysts note high P/E ratio and insider selling as cautionary signs for investors.